CPSF6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.717000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.947400E-01
Normal-vs-Stage2
3.145400E-01
Normal-vs-Stage3
1.066040E-01
Normal-vs-Stage4
4.973400E-01
Stage1-vs-Stage2
7.253400E-01
Stage1-vs-Stage3
6.216200E-02
Stage1-vs-Stage4
9.867000E-01
Stage2-vs-Stage3
3.042600E-01
Stage2-vs-Stage4
7.832400E-01
Stage3-vs-Stage4
1.300220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.955500E-02
Normal-vs-AfricanAmerican
2.666200E-01
Normal-vs-Asian
9.887600E-01
Caucasian-vs-AfricanAmerican
9.935000E-01
Caucasian-vs-Asian
5.341400E-01
AfricanAmerican-vs-Asian
5.461400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.620000E-01
Normal-vs-Female
2.903900E-02
Male-vs-Female
1.178180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.414800E-01
Normal-vs-Age(41-60Yrs)
7.010600E-01
Normal-vs-Age(61-80Yrs)
3.634100E-02
Normal-vs-Age(81-100Yrs)
3.270600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.814600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.112600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.349400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.704000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.861600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.162200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.927500E-02
Normal-vs-Daily Drinker
4.400100E-02
Normal-vs-Weekly Drinker
1.045380E-01
Normal-vs-Occasional Drinker
9.386600E-01
Normal-vs-Social Drinker
4.069600E-01
Non Drinker-vs-Daily Drinker
6.540400E-01
Non Drinker-vs-Weekly Drinker
8.635400E-01
Non Drinker-vs-Occasional Drinker
1.474570E-01
Non Drinker-vs-Social Drinker
4.801000E-01
Daily Drinker-vs-Weekly Drinker
8.558600E-01
Daily Drinker-vs-Occasional Drinker
1.220180E-01
Daily Drinker-vs-Social Drinker
3.067600E-01
Weekly Drinker-vs-Occasional Drinker
1.435200E-01
Weekly Drinker-vs-Social Drinker
4.869000E-01
Occasional Drinker-vs-Social Drinker
2.090000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.043700E-02
Normal-vs-Grade 2
1.852380E-01
Normal-vs-Grade 3
5.822300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.115400E-01
Grade 1-vs-Grade 3
5.621200E-01
Grade 1-vs-Grade 4
8.043700E-02
Grade 2-vs-Grade 3
4.998000E-01
Grade 2-vs-Grade 4
1.852380E-01
Grade 3-vs-Grade 4
5.822300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.957800E-02
Normal-vs-NonDiabetic
3.614800E-01
Diabetic-vs-NonDiabetic
1.369050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.696000E-01
Normal-vs-NoPancreatitis
3.285800E-01
Pancreatitis-vs-NoPancreatitis
3.883500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.871600E-02
Normal-vs-N1
4.710000E-02
N0-vs-N1
7.080600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.789200E-01
Normal-vs-TP53-NonMutant
3.006000E-01
TP53-Mutant-vs-TP53-NonMutant
5.289000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
